Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound.

Saved in:
Bibliographic Details
Title: Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound.
Authors: Okoye AA; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Vaidya M; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Fukazawa Y; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Park H; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Duell DM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Lum R; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Hughes CM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Ventura AB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Ainslie E; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Ford JC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Morrow D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Gilbride RM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Legasse AW; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Hesselgesser J; Gilead Sciences, Inc., Foster City, CA, USA., Geleziunas R; Gilead Sciences, Inc., Foster City, CA, USA., Li Y; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Oswald K; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Shoemaker R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Fast R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Bosche WJ; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Borate BR; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Edlefsen PT; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Axthelm MK; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA., Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA. pickerl@ohsu.edu., Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. lifsonj@mail.nih.gov.
Source: Nature medicine [Nat Med] 2018 Sep; Vol. 24 (9), pp. 1430-1440. Date of Electronic Publication: 2018 Aug 06.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30082858
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Okoye+AA%22">Okoye AA</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Hansen+SG%22">Hansen SG</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Vaidya+M%22">Vaidya M</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Fukazawa+Y%22">Fukazawa Y</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Park+H%22">Park H</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Duell+DM%22">Duell DM</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Lum+R%22">Lum R</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Hughes+CM%22">Hughes CM</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Ventura+AB%22">Ventura AB</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Ainslie+E%22">Ainslie E</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Ford+JC%22">Ford JC</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Morrow+D%22">Morrow D</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Gilbride+RM%22">Gilbride RM</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Legasse+AW%22">Legasse AW</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Hesselgesser+J%22">Hesselgesser J</searchLink>; Gilead Sciences, Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Geleziunas+R%22">Geleziunas R</searchLink>; Gilead Sciences, Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Oswald+K%22">Oswald K</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Shoemaker+R%22">Shoemaker R</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Fast+R%22">Fast R</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Bosche+WJ%22">Bosche WJ</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Borate+BR%22">Borate BR</searchLink>; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Edlefsen+PT%22">Edlefsen PT</searchLink>; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Axthelm+MK%22">Axthelm MK</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.<br /><searchLink fieldCode="AU" term="%22Picker+LJ%22">Picker LJ</searchLink>; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA. pickerl@ohsu.edu.<br /><searchLink fieldCode="AU" term="%22Lifson+JD%22">Lifson JD</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA. lifsonj@mail.nih.gov.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2018 Sep; Vol. 24 (9), pp. 1430-1440. <i>Date of Electronic Publication: </i>2018 Aug 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30082858
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41591-018-0130-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1430
    Titles:
      – TitleFull: Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Okoye AA
      – PersonEntity:
          Name:
            NameFull: Hansen SG
      – PersonEntity:
          Name:
            NameFull: Vaidya M
      – PersonEntity:
          Name:
            NameFull: Fukazawa Y
      – PersonEntity:
          Name:
            NameFull: Park H
      – PersonEntity:
          Name:
            NameFull: Duell DM
      – PersonEntity:
          Name:
            NameFull: Lum R
      – PersonEntity:
          Name:
            NameFull: Hughes CM
      – PersonEntity:
          Name:
            NameFull: Ventura AB
      – PersonEntity:
          Name:
            NameFull: Ainslie E
      – PersonEntity:
          Name:
            NameFull: Ford JC
      – PersonEntity:
          Name:
            NameFull: Morrow D
      – PersonEntity:
          Name:
            NameFull: Gilbride RM
      – PersonEntity:
          Name:
            NameFull: Legasse AW
      – PersonEntity:
          Name:
            NameFull: Hesselgesser J
      – PersonEntity:
          Name:
            NameFull: Geleziunas R
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Oswald K
      – PersonEntity:
          Name:
            NameFull: Shoemaker R
      – PersonEntity:
          Name:
            NameFull: Fast R
      – PersonEntity:
          Name:
            NameFull: Bosche WJ
      – PersonEntity:
          Name:
            NameFull: Borate BR
      – PersonEntity:
          Name:
            NameFull: Edlefsen PT
      – PersonEntity:
          Name:
            NameFull: Axthelm MK
      – PersonEntity:
          Name:
            NameFull: Picker LJ
      – PersonEntity:
          Name:
            NameFull: Lifson JD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2018 Sep
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1546-170X
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Nature medicine
              Type: main
ResultId 1